Health Panel Urges Restarting J&J VaccinationsHealth Panel Urges Restarting J&J VaccinationsA U.S. health panel says it's time to resume use of Johnson & Johnson's COVID-19 vaccine, despite a very rare risk of blood clots.The Associated PressThe Associated Press
